HIV 1 News and Research

RSS

Researchers, decision makers, and people with HIV to attend Ontario HIV Treatment Network's conference

The 11th annual research conference of the Ontario HIV Treatment Network will examine the factors that increase risk for individuals and communities most affected by HIV, as well as interventions that may improve the lives of people living with HIV and prevent the spread of the virus.

16 Nov 2009

SPOT: A one-stop HIV and sexually transmitted diseases testing center for youth

In the last 10 years, the St. Louis area has seen an alarming increase in new diagnoses of HIV and sexually transmitted infections among 13-24 year-olds. Between 1997-2007, more than 50 new diagnoses of HIV were made each year among adolescents and young adults, who are often disconnected from the health-care system or support services. Nationwide, St. Louis has among the highest rates of sexually transmitted diseases in this age group.

16 Nov 2009

Inovio Biomedical reports financial results for the three and nine months ended September 30, 2009

Inovio Biomedical Corporation today reported financial results for the three and nine months ended September 30, 2009.

16 Nov 2009

New faces of HIV/AIDS: A report

World AIDS Day 2009 will be marked with both grim and hopeful data: more than 25 million people have died of AIDS worldwide since 1981; 33 million are living with HIV/AIDS. While potent, effective medications have changed an HIV diagnosis from death sentence to manageable chronic illness in resource rich countries, global rates of infection still outstrip prevention and treatment capacity.

16 Nov 2009

Recent releases in Global Health

As a follow-up to a survey conducted in May 2009, this poll examines Americans' attitudes toward U.S. global health investments and priorities.

16 Nov 2009

NIDA awards $17 million to University of California to establish TMARC

Igor Grant, MD, professor of psychiatry at the University of California, San Diego School of Medicine, and colleagues have been awarded a $17 million grant from the National Institute on Drug Abuse to establish the Translational Methamphetamine AIDS Research Center (TMARC) at UC San Diego. Grant is director of the HIV Neurobehavioral Research Center (HNRC), a clinical research center designated and funded by the National Institute of Mental Health.

16 Nov 2009

Chembio Diagnostics to donate more than 4,500 rapid HIV test kits

Chembio Diagnostics, Inc., a NY-based company that develops, manufactures, licenses and markets proprietary rapid diagnostic tests, is donating more than 4,500 rapid HIV test kits to the AIDS Healthcare Foundation's 2009 Testing Millions Global Campaign, based in Los Angeles, to commemorate World AIDS Day 2009 on December 1st.

16 Nov 2009

Global Fund approves $2.4B for ninth round grants

During its recent board meeting in Addis Ababa, Ethiopia, the Global Fund to Fight AIDS, Tuberculosis and Malaria approved $2.4 billion for the three diseases, PlusNews reports.

16 Nov 2009

DC HIV study: Can intense treatment prevent spread

The Washington Post: "The National Institutes of Health and the D.C. Health Department are preparing to launch a study in the District with an ambitious goal: to determine whether aggressive treatment of every adult with HIV could eliminate AIDS." In conjunction with the study, NIH will provide experts to the city health department to help modernize clinic record-keeping efforts and to improve the tracking of HIV-infected people.

13 Nov 2009

Scientists describe how HIV assemble at the membrane of infected cells and are released to attack healthy cells

Although recent advances have raised hopes that a protective vaccine can be developed, acquired immunodeficiency syndrome (AIDS) remains a major public health problem. Much has been learned about HIV-1, the virus that causes the disease.

13 Nov 2009

Nutra Pharma to market its OTC pain reliever in Brazil and Colombia, begins the drug registration process

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it plans to begin the drug registration process in Brazil and Colombia for its over-the-counter (OTC) pain reliever. The company is currently marketing a similar drug in the United States under the brand name Cobroxin for the treatment of moderate to severe (Stage 2) chronic pain.

13 Nov 2009

New findings on human genome may be useful for developing specific AIDS drugs

The AIDS virus inserts its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center have now shown for the first time that the virus almost entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs.

13 Nov 2009

Health minister calls for ramped up fight against HIV/AIDS in South Africa

South African health minister Aaron Motsoaledi on Tuesday called for a reinvigorated effort in the country's fight against HIV/AIDS, echoing comments recently made by South African President Jacob Zuma, Agence France-Presse reports. Motsoaledi said to reporters, "In 11 years - from 1997 to 2008 - the rate of death has doubled in South Africa" (11/10).

12 Nov 2009

Tips for preventing cancer

The risk of cancer can be dramatically reduced through everyday choices about diet, exercise and tobacco use, according to a Special Report on Cancer Prevention in the November issue of Mayo Clinic Women's HealthSource.

12 Nov 2009

HUD threatens to block Washington D.C.'s AIDS funding

The U.S. Department of Housing and Urban Development is threatening to halt federal funding for the Washington D.C.'s AIDS programs after a Washington Post investigation found many delivered faulty services and failed to account for their work.

12 Nov 2009

Tobira Therapeutics presents data on TBR-652 at the European AIDS Conference

Tobira Therapeutics, a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced pharmacokinetic data and results from two double-blind, placebo-controlled studies of TBR-652 in eighty-four healthy volunteers.

12 Nov 2009

Pan-African conference to focus on the rapid growth of diabetes in Africa

The Republic of Mauritius in collaboration with the World Health Organization Afro Region and the International Diabetes Federation (IDF) today opened an International Conference on Diabetes & Associated Diseases in Port Louis, Mauritius to highlight their concern about the rapid growth of the diabetes epidemic throughout Africa. The conference will run from November 12 and end on November 14 – World Diabetes Day.

11 Nov 2009

World's poorest countries fail to address HIV despite low cost and effective preventive health efforts

A proven and cost-effective strategy for turning the tide on global AIDS still remains significantly underutilized, World Vision warned in advance of World AIDS Day. Efforts to prevent mother-to-baby transmission of HIV must be urgently scaled up in high-prevalence countries to avoid needless infection of children, the Christian humanitarian organization said.

11 Nov 2009

HIV/AIDS leading cause of death among women ages 15-44, WHO study shows

In follow-up coverage to the WHO's report on women's health, several news outlets examine the impact HIV/AIDS is having on women around the world. "In its first study of women's health, the World Health Organization said yesterday that the AIDS virus is the leading cause of death and disease among women between the ages of 15 and 44," the Associated Press/Boston Globe reports (11/10).

11 Nov 2009

NIH awards $6.8 million subcontract to Kineta to develop vaccine immune boosters

Kineta, Inc. announced today it has been awarded a $6.8 million subcontract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop novel vaccine adjuvants (agents that help boost the immune system). The Kineta subcontract is part of a larger $13 million award to the University of Washington.

10 Nov 2009